Definitive Healthcare debuts data-agnostic analytics platform for life sciences applications

Definitive Healthcare (Nasdaq:DH) has launched the Passport Analytics Suite, a product line intended to facilitate the development, launch and commercialization of life science products.

The Passport Analytics Suite integrates technology from Framingham, Massachusetts-based Definitive Healthcare’s acquisition of Analytical Wizards in February 2022. Analytical Wizards is an advanced analytics company catering to the healthcare market. Having been branded as a ‘Definitive Healthcare company,’ Analytical Wizards will remain a standalone company,

One notable customer of Analytical Wizards is Sanofi (Nasdaq:SNY), which uses its technology to integrate data and run analytics at scale to drive strategic decision-making.

Similarly, the Passport Analytics Suite provides life sciences organizations with tools to establish an analytics-driven on-demand environment at scale.

“With these tools, clients can effectively assess and optimize brand performance and dial in the optimal promotional mix,” said Jason Krantz, founder and CEO of Definitive Healthcare, in a press release. “The Passport Analytics Suite helps clients optimize the entire commercialization process, from early-stage business planning needs through post-launch performance acceleration.”

The Passport Analytics Suite can incorporate data from either cloud or IT infrastructure.

“The Passport Analytics Suite is unique in its ability to combine AI-driven data science methodologies with deep expertise in the life sciences,” said Ram Sharma, founder and CEO of Analytical Wizards. “The Passport Analytics Suite delivers configurable analytics on-demand, allowing clients to cut and re-cut data as they want in a secure, self-service environment. The easy-to-use products enable team members from across an organization to create value by reporting on a single source of truth, and then looking at it from multiple angles.”